Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor organoids: applications in cancer modeling and potentials in precision medicine
Hanxiao Xu, Dechao Jiao, Aiguo Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Organoid, organ-on-a-chip and traditional Chinese medicine
Jiayue Yang, Yu Jiang, Mingxing Li, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
A clinician’s perspective: what tumor-organoid researchers ought to know
Jeong Uk Lim
Organoid (2025) Vol. 5, pp. e1-e1
Open Access
The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
Eleonore Fröhlich
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7116-7116
Open Access | Times Cited: 18
Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 16
Omics-based molecular classifications empowering in precision oncology
Zhaokai Zhou, Ting Lin, Shuang Chen, et al.
Cellular Oncology (2024) Vol. 47, Iss. 3, pp. 759-777
Closed Access | Times Cited: 5
Organoids as preclinical models of human disease: progress and applications
Baodan Chen, Cijie Du, Mengfei Wang, et al.
Medical Review (2024) Vol. 4, Iss. 2, pp. 129-153
Open Access | Times Cited: 5
Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**
Zihan Zhao, Shuren Zhang, Ning Jiang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 9
Closed Access | Times Cited: 4
Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation
Abel Soto-Gamez, Jeremy P. Gunawan, Lara Barazzuol, et al.
Stem Cells (2024) Vol. 42, Iss. 6, pp. 499-508
Open Access | Times Cited: 4
Patient-derived organoids in precision cancer medicine
Le Tong, Weiyingqi Cui, Boya Zhang, et al.
Med (2024)
Open Access | Times Cited: 4
Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer
Anamitra Bhattacharya, Kamare Alam, Nakka Sharmila Roy, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids
Lanxiang Huang, Yaqi Xu, Na Wang, et al.
Small Methods (2023) Vol. 8, Iss. 1
Closed Access | Times Cited: 12
Advances in Microfluidic Technologies in Organoid Research
Haitao Liu, Zhongqiao Gan, Xinyuan Qin, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 21
Closed Access | Times Cited: 12
Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids
Xian Lin, Dong Chen, Xinyu Chu, et al.
Phytomedicine (2023) Vol. 114, pp. 154752-154752
Closed Access | Times Cited: 11
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Ximin Tan, Deguang Kong, Zhuoli Tao, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Incorporating Immune Cells into Organoid Models: Essential for Studying Human Disease
Ania Bogoslowski, Meilin An, Josef Penninger
Organoids (2023) Vol. 2, Iss. 3, pp. 140-155
Open Access | Times Cited: 10
Polydopamine-Based Resveratrol-Hyaluronidase Nanomedicine Inhibited Pancreatic Cancer Cell Invasive Phenotype in Hyaluronic Acid Enrichment Tumor Sphere Model
Shuo Yu, Lu Zhang, Yanshen Yang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 1013-1022
Open Access | Times Cited: 3
Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications
Hui Jun Lim, Lizhe Zhuang, Rebecca C. Fitzgerald
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9
Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer
Yuting Tang, Ting Wang, Yaowen Hu, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107116-107116
Open Access | Times Cited: 8
Biohybrid Hydrogels for Tumoroid Culture
Miquel Castellote‐Borrell, Francesca Merlina, Adrián R. Rodríguez, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 8
Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer
Praopim Limsakul, Pongsakorn Choochuen, Thawirasm Jungrungrueang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1405-1405
Open Access | Times Cited: 2
Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models
Katie Hamel, Trivia Frazier, Christopher Williams, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2728-2728
Open Access | Times Cited: 2
SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids
Sanjit K. Roy, Tijana Đukić, Zachery Keepers, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research
Sicheng Yan, Yuxuan He, Yuehong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Biomimetic hydrogels with mesoscale collagen architecture for patient-derived tumor organoids culture
Jiaxin Wang, Zhilin Sui, Wei Huang, et al.
Bioactive Materials (2024) Vol. 38, pp. 384-398
Open Access | Times Cited: 2
Intratumoral metabolic heterogeneity by 18F‐FDG PET/CT to predict prognosis for patients with thymic epithelial tumors
Fangfang Chao, Ran Wang, Xingmin Han, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 18, pp. 1437-1445
Open Access | Times Cited: 2

Scroll to top